Read next
Clinical Trials Accelerate Deployment of Synthetic Control Arms
Pharmaceutical firms leverage historical patient data to reduce trial costs and speed regulatory submission timelines.
Digital Therapeutics Face Regulatory and Reimbursement Hurdles in European Markets
Prescription software applications encounter varying country-by-country approval pathways despite unified clinical safety guidelines.
The Law Review – Laws Of Attraction
Sometimes it is better to intend nothing and only let life carry you along significantly beautiful river it…
GLP-1 Supply Pressures Trigger Expansion in Synthetic Manufacturing Capacity
Pharmaceutical majors invest heavily in localized fill-finish infrastructure to clear global production backlogs.
Hundreds of Millions Live With Conditions That Began as an Infection
Post-infection illness is far more common than the attention it receives, and research into why some people do…
Predictive Analytics Shorten Clinical Trial Protocols in Oncology
Pharmaceutical firms are leveraging predictive analytics to optimize patient cohort selection and accelerate phase two clinical trials.